CAPTRUST Financial Advisors
CABA icon

CAPTRUST Financial Advisors’s Cabaletta Bio CABA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200
Closed – – 2353
2022
Q2 		$0 Hold
200
– – ﹤0.01% 4943
2022
Q1 		$0 Hold
200
– – ﹤0.01% 4932
2021
Q4 		$1K Hold
200
– – ﹤0.01% 4541
2021
Q3 		$2K Hold
200
– – ﹤0.01% 4236
2021
Q2 		$2K Hold
200
– – ﹤0.01% 4149
2021
Q1 		$2K Buy
+200
New +$2.44K ﹤0.01% 4017

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CAPTRUST Financial Advisors's CABA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Cabaletta Bio (CABA) in Q3 2022, closing a stake of 200 shares.

CAPTRUST Financial Advisors first reported a position in CABA in Q1 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2021. 54 funds tracked by Wall St. Rank hold CABA as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Cabaletta Bio position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 200 Cabaletta Bio shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in Cabaletta Bio in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Cabaletta Bio position peaked at $2K in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.